AI assistant
GlaxoSmithKline PLC — Director's Dealing 2014
Oct 1, 2014
5262_dirs_2014-10-01_b0e41087-96b6-4247-84b4-699bc2a3a963.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1996T
GlaxoSmithKline PLC
01 October 2014
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc (GSK) was advised on 1 October 2014, that on 30 September 2014 the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.22 per Ordinary Share, and notional ADSs at a price of $46.31 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2014 to 30 September 2014:
| Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
| Sir Christopher Gent | 4,395.218 | |
| Professor Sir Roy Anderson | 505.450 | |
| Dr Stephanie Burns | 633.729 | |
| Stacey Cartwright | 373.594 | |
| Lynn Elsenhans | 1,140.713 | |
| Judy Lewent | 491.686 | |
| Sir Deryck Maughan | 1,529.691 | |
| Dr Daniel Podolsky | 1,147.268 | |
| Tom de Swaan | 461.498 | |
| Jing Ulrich | 316.865 | |
| Hans Wijers | 373.594 |
V A Whyte
Company Secretary
1 October 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSZFLFBZBFBFBE